SCHEMBL18530607

SCHEMBL18530607

CN(C(=O)O)c1ccc(-c2ccc(-c3ccc(C(=O)N4CC(F)(F)C4)cc3)cc2C(F)(F)F)o1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CCNC P24863 3/20 0.37
▸ CDK8 P49336 3/20 0.37
▸ ERN1 O75460 1/20 0.36
▸ CECR2 Q9BXF3 1/20 0.36
▸ LIPC P11150 3/20 0.34
▸ LIPG Q9Y5X9 3/20 0.34
▸ LRRK2 Q5S007 1/20 0.34
▸ GPR119 Q8TDV5 1/20 0.33
▸ ATR Q13535 1/20 0.33
▸ RARB P10826 2/20 0.33
▸ GRIN2B Q13224 1/20 0.33
▸ DPP4 P27487 1/20 0.33
▸ DPP7 Q9UHL4 1/20 0.33
▸ SRD5A2 P31213 1/20 0.32
▸ HDAC4 P56524 1/20 0.32
▸ PDK2 Q15119 1/20 0.32
▸ KDM1A O60341 1/20 0.32
▸ RARA P10276 1/20 0.32
▸ RARG P13631 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18530646 0.85 CCNC (0.38) CCNCCDK8ERN1CECR2LIPC
SCHEMBL18530623 0.83 ATR (0.38) CCNCCDK8ERN1CECR2LIPC
SCHEMBL19066850 0.81 ERN1 (0.38) CCNCCDK8ERN1CECR2LIPC
SCHEMBL18530498 0.81 ERN1 (0.37) CCNCCDK8ERN1CECR2LIPC
SCHEMBL18530605 0.80 ATR (0.39) ATR
SCHEMBL18530606 0.80 LIPC (0.39) CCNCCDK8ERN1CECR2LIPC
SCHEMBL18530595 0.79 LRRK2 (0.37) CCNCCDK8LRRK2GPR119ATR
SCHEMBL18530503 0.76 PAK4 (0.41) DPP4DPP7
SCHEMBL18542148 0.76 LIPC (0.37) ERN1LIPCLIPGLRRK2GPR119
SCHEMBL18530633 0.75 CCNC (0.40) CCNCCDK8ERN1LIPCLIPG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3337796-A1 3-(PYRIDIN-3-YL)-ACRYLAMIDE AND N-(PYRIDIN-3-YL)-ACRYLAMIDE DERIVATIVES AND THEIR USE AS PAK OR NAMPT MODULATORS Karyopharm Therapeutics, Inc. (US) 2018-06-27 — — EP disclosed
WO-2017031213-A1 3-(PYRIDIN-3-YL)-ACRYLAMIDE AND N-(PYRIDIN-3-YL)-ACRYLAMIDE DERIVATIVES AND THEIR USE AS PAK OR NAMPT MODULATORS Karyopharm Therapeutics Inc. (US) 2017-02-23 — — WO disclosed
Send feedback